6 ms·
You seem to know a lot about this, and I was nodding along with a lot of your points as I was reading. I was Stripe's first customer in 2010, so we solved the
by lloydarmbrust 14d ago
You seem to know a lot about this, and I was nodding along with a lot of your points as I was reading.
I was Stripe's first customer in 2010, so we solved the credit card processing issue :) it turns out that being in YC is good for more than just money.
You are right about HIPAA, everyone thinks this is much harder than it actually is, but GCP, OpenAI, Linq, everyone has given us a BAA.
We're definitely not trying to go after the market of people that are comfortable buying from Chinese suppliers and risking their health. When I built my mask factory, our masks were absolutely more expensive than Chinese masks, but what people were buying was a guarantee that it would meet certain filtration requirements. Some people are willing to pay for safety, but it's not important to everyone.
The only thing I really disagree with with you on is that this isn't a YC-scale company.
We are growing 56% compounded week -over-week, and I have every expectation we'll do $10 million this year, $100 million next.
We are making something that people are already buying and getting it to them in a safer, more cost-effective way.
- intoXbox 14d agoDon’t newly produced meds require new FDA clearance/approval, with clinical testing and all the like? I mean how else can you prove that your new drug production is effective and causes no new harms
- hypendev 14d ago> I was Stripe's first customer in 2010 Would love to hear more about this, sounds like a fun time. Are you planning to move from peptides to generics in the future? Also, considering you are looking at full vertical integration, is blood testing going to be a part of the pipeline in the future or will you partner with service providers? (I assume the latter until you grow enough to expand into that?) While peptides are currently the hot market, I definitely can see the feedback loop being a great growth driver. Having a "hands-off" medication management with doses changing based on periodical labs result would be amazing - I am on a generic med (T4) for an autoimmune, and the process is annoying: - Get labs done - Schedule an endocrinologist, wait - Reach out to my GP, have them bump my medications - Wait for them to answer/arrange a checkup - Wait for it to clear with the pharmacy - Repeat If this could be condensed in a loop that is basically get labs done -> pick up prescription, it would both reduce waiting time and reduce pressure on the med system, plus could be a huge data source on drug interactions. Oh, and one last thing - considering the peptide market is currently full of grey/black market companies, drop-shippers and affiliate resellers, how do you plan to market it? Especially judging by the site design, if I saw this link elsewhere I'd think it was AI dropshipping slop - no offense - mostly due to classic Claude design and the AI generated bottle/video. Besides that, congratulations on the launch - love the vision and the future it can bring, hope you become at least a decacorn!
- piker 14d ago> You seem to know a lot about this, and I was nodding along with a lot of your points as I was reading. Hire rootsudo? Email in the profile.
- pstuart 13d ago> We're definitely not trying to go after the market of people that are comfortable buying from Chinese suppliers and risking their health Just being able to buy from a truly trusted vendor and not pay big pharma markup and I'm there. "Personalized" sounds cool, but all of that is fluff around affordable and trustable meds.